The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.42
Bid: 17.42
Ask: 18.08
Change: 0.14 (0.80%)
Spread: 0.66 (3.789%)
Open: 17.42
High: 17.42
Low: 17.42
Prev. Close: 17.61
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

27 Sep 2013 07:00

RNS Number : 0608P
Nanoco Group PLC
27 September 2013
 



For immediate release

27 September 2013

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Corporate Update

 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, is pleased to announce the following corporate update.

 

Nanoco has completed the planned expansion of its cadmium-free quantum dot production facility in Runcorn with the installation and commissioning of two further Semi-Tech lines at a planned cost of approximately £1.25 million.

 

These Semi-Tech lines will be used to fulfil orders for large quantities of sample materials to meet increasing demand for pre-production quantum dots from customers and potential customers across the Company's target markets.

 

Nanoco also announces that the terms of its global licensing agreement with The Dow Chemical Company ("Dow") have been amended to accelerate the commercialisation of Nanoco's cadmium-free quantum dot technology in the display market.

 

Under the new terms, Dow continues to hold exclusive worldwide rights for the sale, marketing and manufacture of Nanoco's cadmium-free quantum dots for use in electronic displays.

 

Changes in the new agreement include the waiving of the requirement for Nanoco to contribute capital to the production plant Dow is preparing to build in Asia. In return, the royalty rate that Nanoco would receive from Dow's sale of quantum dots has been reduced to reflect the changes to the agreement. The adjusted royalties continue to acknowledge the proprietary value of Nanoco's technology. Financial details and other specifics are not being disclosed. The agreement does not include specifics about the anticipated price and volume of quantum dots as these are a function of commercial negotiations with customers. 

 

Dow and Nanoco have committed additional resources to accelerate commercialisation and full production under the licensing agreement is expected to begin in the first half of 2014.

 

Nanoco continues to make progress in its other core target markets of general lighting and solar energy. Notably, the Company's photovoltaic ink is now achieving an energy conversion efficiency of between 12 per cent and 13 per cent.

 

 

Michael Edelman, Nanoco's Chief Executive Officer, commented: "We have been delighted by the progress made by Dow. The amendments to the agreement with Dow better capitalise on our respective strengths and reinforce our collective commitment to commercialise this technology as quickly as possible to meet future market demand.

 

"We have also continued to make encouraging progress across our business, including a doubling of capacity at Runcorn to meet increasing demand for pre-production samples from display and other customers."

 

 

For further information:

 

Nanoco

+ 44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Colin White, Chief Financial Officer

Canaccord Genuity - Nomad and Joint Broker

+44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Liberum Capital - Joint Broker

+44 (0) 20 3100 2000

Simon Atkinson

Richard Bootle

Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Fiona Henson / Sophie Cowles

 

 

Notes for editors:

 

About Nanoco Group plc

 

Nanoco is a world leader in the development and production of cadmium-free quantum dots for use in multiple applications including LCD displays, lighting and solar cells. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and business development offices in the USA, Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKADPDBKBBCB
Date   Source Headline
17th Sep 20187:00 amRNSHolding(s) in Company
11th Sep 20187:00 amRNSInvestor day
5th Sep 20182:21 pmRNSHolding(s) in Company
17th Aug 201811:28 amRNSHolding(s) in Company - Replacement
15th Aug 20184:47 pmRNSHolding(s) in Company
15th Aug 20187:00 amRNSYear End Trading Update and Notice of Results
9th Aug 20183:56 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSDirectorate Changes
11th Jul 201812:07 pmRNSSecond Price Monitoring Extn
11th Jul 201812:02 pmRNSPrice Monitoring Extension
2nd Jul 201811:18 amRNSHolding(s) in Company
29th Jun 201811:50 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSDirectorate Change
8th Jun 20187:00 amRNSBlock listing Interim Review
15th May 20183:58 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSNanoco Announces Major Milestone Payment
2nd May 20187:00 amRNSLaunch of Nanoco 2D Materials Ltd
23rd Apr 20187:00 amRNSExpansion of Material Development Agreement
16th Apr 201811:41 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSHalf-year Results
15th Mar 201810:47 amRNSHolding(s) in Company
15th Mar 20187:00 amRNSNotice of Results
28th Feb 20182:34 pmRNSHolding(s) in Company
9th Feb 201812:59 pmRNSHolding(s) in Company
8th Feb 20187:00 amRNSMaterial Development and Supply Agreement
5th Feb 201812:39 pmRNSHolding(s) in Company
16th Jan 20184:45 pmRNSBLOCKLISTING SIX-MONTHLY RETURN
12th Jan 20182:48 pmRNSResult of AGM
12th Jan 20187:00 amRNSAGM Statement
2nd Jan 201812:07 pmRNSSecond Price Monitoring Extn
2nd Jan 201812:02 pmRNSPrice Monitoring Extension
29th Dec 201712:40 pmRNSSecond Price Monitoring Extn
29th Dec 201712:35 pmRNSPrice Monitoring Extension
19th Dec 20171:11 pmRNSHolding(s) in Company
18th Dec 20171:24 pmRNSHolding(s) in Company
12th Dec 201712:07 pmRNSSecond Price Monitoring Extn
12th Dec 201712:02 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSDirector/PDMR Shareholding
4th Dec 20177:00 amRNSCommercial Supply and License Agreement
30th Nov 20174:43 pmRNSSecond Price Monitoring Extn
30th Nov 20174:35 pmRNSPrice Monitoring Extension
30th Nov 201712:31 pmRNSHolding(s) in Company
30th Nov 20177:00 amRNSAnnual Financial Report
16th Nov 20174:50 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSPreliminary Results
15th Nov 201710:42 amRNSDirector/PDMR Shareholding
14th Nov 20171:38 pmRNSResult of General Meeting
14th Nov 20177:00 amRNSWebcast of Full Year Results
8th Nov 201712:08 pmRNSHolding(s) in Company
2nd Nov 201710:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.